DCGO DocGo Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 17, 2026
$0,37
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,3152-Wochen-Tief
$1,6552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$37M
P/E (TTM)
-0.2
EPS (TTM)
$-1.95
Umsatz (TTM)
$295M
Ihre Abzeichen
52W-Spanne
$0–$2
Analystenbewertung
BUY
Kursziel
$2
P/E
-0.2
ROE
-92.4%
Nettogewinnmarge
-65.3%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
DCGO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.37
Marktkapitalisierung (MRQ)
$37M
P/E (TTM)
-0.2
EPS (TTM)
$-1.95
Umsatz (TTM)
$295M
ROE (TTM)
-92.4%
Verschuldungsgrad (MRQ)
0.0
52W-Spanne
$0–$2
DCGO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$322M2023-12-31 → 2025-12-31
EPS$-1.842023-12-31 → 2025-12-31
Freier Cashflow$30M2023-12-31 → 2025-12-31
Nettogewinnmarge-65.3%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | DCGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -0.2 | · | · | · | |
| P/S (TTM) | 0.1 | · | 1.0 | Unterbewertet | |
| K/B (MRQ) | 0.3 | · | 3.0 | Unterbewertet | |
| EV / EBITDA | 0.1 | · | · | · | |
| Kurs / FCF (TTM) | -1.4 | · | · | · | |
| Kurs / Cashflow (TTM) | -1.6 | · | 25.4 | Unterbewertet | |
| EV / Revenue (EV / Umsatz) | -0.0 | · | · | · | |
| EV / FCF | -0.5 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 0.3 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | DCGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -62.2% | · | -0.07% | Schwach | |
| EBITDA-Marge (TTM) | -57.7% | · | 1.9% | Schwach | |
| Vorgewinnmarge (TTM) | -64.3% | · | -2.8% | Schwach | |
| Nettogewinnmarge (TTM) | -65.3% | · | -2.6% | Schwach | |
| ROA (TTM) | -64.7% | · | -3.9% | Schwach | |
| ROE (TTM) | -92.4% | · | -7.9% | Schwach | |
| ROIC | -129.2% | · | -6.8% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | DCGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.0 | · | 0.0 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.7 | · | 1.1 | Starke Liquidität | |
| Quick Ratio | 2.1 | · | 0.9 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.0 | · | 0.2 | Geringe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | DCGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -47.7% | · | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -9.9% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 27.9% | · | · | · | |
| EPS YoY (EPS VjV) | 200.0% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | 191.5% | · | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -10.4% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 1.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | DCGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.0 | · | 1.1 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 2.1 | · | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$127.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-238.5%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 17, 2026 | $-0.16 | $-0.06 | -153.2% |
| 31. März 2026 | Mai 6, 2026 | $-0.13 | $-0.10 | -36.6% |
| 31. Dezember 2025 | $-1.37 | $-0.13 | -920.1% | |
| 30. September 2025 | $-0.11 | $-0.12 | 4.2% | |
| 30. Juni 2025 | $-0.11 | $-0.10 | -14.3% | |
| 31. März 2025 | $-0.09 | $-0.02 | -311.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $322M | $617M | $624M | $441M | $319M | $94M | |
| Cost of Revenue | · | · | · | $524M | $452M | · | |
| R&D Expense | $14M | $12M | $11M | $5M | $3M | $1M | |
| SG&A Expense | $133M | $139M | $137M | $103M | $75M | $35M | |
| Operating Expenses | $500M | $588M | $609M | $419M | $303M | $109M | |
| Operating Income | $-178M | $29M | $15M | $22M | $15M | $-15M | |
| Other Non-op | $-532.4K | $228.7K | $-686.9K | $-987.5K | $-40.1K | $300.0K | |
| Pretax Income | $-187M | $28M | $16M | $23M | $20M | $-15M | |
| Income Tax | $9M | $14M | $6M | $-8M | $615.7K | $167.4K | |
| Net Income | $-182M | $20M | $7M | $31M | $19M | $-15M | |
| EPS (Basic) | $-1.84 | $0.20 | $0.07 | $0.34 | $0.30 | $-0.25 | |
| EPS (Diluted) | $-1.84 | $0.18 | $0.06 | $0.34 | $0.25 | $-0.25 | |
| Shares (Basic) | 99,068,651 | 102,395,141 | 103,511,299 | 101,228,369 | 80,293,959 | 58,370,157 | |
| Shares (Diluted) | 99,068,651 | 109,422,840 | 105,617,817 | 102,975,831 | 94,863,613 | 58,370,157 | |
| EBITDA | $-162M | $45M | $20M | $22M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $89M | $59M | $157M | $176M | $32M | |
| Receivables | $93M | $211M | $262M | $103M | $78M | · | |
| Prepaid Expense | $5M | $4M | $17M | $6M | $2M | $1M | |
| Other Current Assets | $4M | $338.7K | · | · | · | $350 | |
| Current Assets | $152M | $304M | $339M | $271M | $256M | $58M | |
| PP&E (Net) | $15M | $15M | $17M | $21M | $13M | $9M | |
| PP&E (Gross) | $36M | $33M | $30M | $30M | $21M | $15M | |
| Accum. Depreciation | $22M | $18M | $13M | $9M | $8M | $6M | |
| Goodwill | $0 | $47M | $48M | $39M | $9M | $7M | |
| Intangibles | $0 | $26M | $38M | $23M | $11M | $11M | |
| Other Non-current Assets | $3M | $4M | $3M | $4M | $4M | $1M | |
| Total Assets | $217M | $456M | $490M | $393M | $310M | $100M | |
| Accounts Payable | $11M | $28M | $20M | $22M | $16M | $4M | |
| Accrued Liabilities | $43M | $50M | $91M | $32M | $35M | $14M | |
| Short-term Debt | $51.7K | $12.5K | $28.1K | $664.9K | $600.4K | $664.4K | |
| Current Liabilities | $67M | $122M | $170M | $100M | $58M | $23M | |
| Capital Leases | $8M | $9M | $7M | $7M | $3M | $4M | |
| Total Liabilities | $91M | $140M | $185M | $114M | $83M | $33M | |
| Long-term Debt | $235.6K | $17.7K | $69.7K | · | · | $142.7K | |
| Total Debt | $287.3K | $30.2K | $97.8K | $1M | · | · | |
| Common Stock | $9.9K | $10.2K | $10.4K | $10.2K | $10.0K | · | |
| Paid-in Capital | $325M | $321M | $321M | $301M | $283M | $142M | |
| Retained Earnings | $-184M | $-1M | $-21M | $-29M | $-64M | $-87M | |
| AOCI | $2M | $1M | $1M | $741.2K | $-32.5K | $-48.5K | |
| Stockholders' Equity | $144M | $321M | $301M | $273M | $220M | $55M | |
| Liabilities + Equity | $217M | $456M | $490M | $393M | $310M | $100M | |
| Shares Outstanding | 98,640,059 | 101,910,883 | 104,055,168 | 102,411,162 | 100,133,953 | 76,489,205 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $16M | $16M | $16M | $11M | $2M | $6M | |
| Stock-based Comp | $17M | $14M | $21M | $8M | $1M | · | |
| Deferred Tax | $8M | $3M | $-2M | $-10M | $0 | · | |
| Amort. of Intangibles | $6M | $6M | $5M | $3M | $2M | $1M | |
| Other Non-cash | $176M | $24M | $-98M | · | · | · | |
| Operating Cash Flow | $34M | $70M | $-64M | $29M | $-2M | $-11M | |
| CapEx | $5M | $4M | $7M | $3M | $5M | $4M | |
| Investing Cash Flow | $-39M | $-11M | $-30M | $-38M | $-9M | $-6M | |
| Stock Issued | · | · | $0 | $0 | $178M | · | |
| Stock Repurchased | $11M | $14M | $0 | $4M | $0 | · | |
| Net Stock Activity | $-11M | $-14M | $0 | $-4M | · | · | |
| Financing Cash Flow | $-51M | $-24M | $1M | $-6M | $155M | $-812.1K | |
| Net Change in Cash | $-55M | $35M | $-92M | $-15M | $145M | $-17M | |
| Taxes Paid | $6M | $6M | $10M | $2M | $615.7K | $117.4K | |
| Free Cash Flow | $30M | $67M | $-72M | $26M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -55.3% | 4.7% | 2.4% | 5.0% | · | · | |
| Net Margin | -56.6% | 2.2% | 1.6% | 7.8% | · | · | |
| Pretax Margin | -58.2% | 4.5% | 2.6% | 5.2% | · | · | |
| EBITDA Margin | -50.4% | 7.2% | 3.2% | 5.0% | · | · | |
| ROA | -54.2% | 2.8% | 2.2% | 9.2% | · | · | |
| ROE | -78.5% | 4.3% | 3.5% | 14.0% | · | · | |
| ROIC | -129.2% | 4.3% | 3.0% | 10.7% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.5 | 2.0 | 2.7 | · | · | |
| Quick Ratio | 2.1 | 2.5 | 1.9 | 1.6 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | 0.0 | 0.0 | 0.0 | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.3 | 1.4 | 1.2 | · | · | |
| Receivables Turnover | 2.1 | 2.6 | 3.4 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.46 | $3.15 | $2.89 | $2.67 | · | · | |
| Revenue / Share | $3.25 | $5.63 | $5.91 | $4.28 | · | · | |
| Cash Flow / Share | $0.35 | $0.64 | $-0.61 | $0.28 | · | · | |
| Cash / Share | $0.52 | $0.88 | $0.57 | $1.54 | · | · | |
| EPS (TTM) | $-1.84 | $0.18 | $0.06 | $0.34 | $0.25 | $-0.25 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -47.7% | -1.2% | 41.7% | 38.2% | 238.7% | · | |
| Revenue CAGR 3Y | -9.9% | 24.6% | 87.9% | · | · | · | |
| Revenue CAGR 5Y | 27.9% | · | · | · | · | · | |
| EPS YoY | · | 200.0% | -82.3% | 36.0% | · | · | |
| EPS CAGR 3Y | · | -10.4% | · | · | · | · | |
| Net Income YoY | · | 191.5% | -77.7% | 60.3% | · | · | |
| Net Income CAGR 3Y | · | 1.4% | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $322M | $617M | $624M | $441M | $319M | $94M | |
| Net Income TTM | $-182M | $20M | $7M | $31M | $19M | $-15M | |
| Market Cap | $87M | $432M | $582M | $724M | · | · | |
| Enterprise Value | $36M | $343M | $522M | $568M | · | · | |
| P/E | -0.5 | 23.6 | 93.2 | 20.8 | 37.4 | -40.6 | |
| P/S | 0.3 | 0.7 | 0.9 | 1.6 | · | · | |
| P/B | 0.6 | 1.3 | 1.9 | 2.6 | · | · | |
| P / Tangible Book | 0.6 | 1.7 | 2.7 | 3.4 | 4.7 | · | |
| P / Cash Flow | 2.5 | 6.1 | -9.1 | 25.1 | · | · | |
| P / FCF | 2.9 | 6.5 | -8.1 | 28.2 | · | · | |
| EV / EBITDA | -0.2 | 7.7 | 26.3 | 26.0 | · | · | |
| EV / FCF | 1.2 | 5.2 | -7.3 | 22.1 | · | · | |
| EV / Revenue | 0.1 | 0.6 | 0.8 | 1.3 | · | · | |
| Earnings Yield | -209.6% | 4.2% | 1.1% | 4.8% | 2.7% | -2.5% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73M | $76M | $75M | $71M | $80M | $96M | $121M | $139M | $165M | $192M | $199M | $187M | $125M | $113M | $109M | $104M | |
| R&D Expense | $3M | $4M | $4M | $3M | $3M | $4M | $4M | $3M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $1M | |
| SG&A Expense | $30M | $31M | $39M | $30M | $31M | $33M | $35M | $29M | $35M | $40M | $44M | $34M | $31M | $29M | $33M | $22M | |
| Operating Expenses | $91M | $94M | $180M | $113M | $98M | $110M | $128M | $129M | $155M | $176M | $188M | $178M | $124M | $120M | $109M | $100M | |
| Operating Income | $-18M | $-19M | $-105M | $-42M | $-17M | $-14M | $-7M | $10M | $10M | $16M | $12M | $9M | $2M | $-7M | $80.1K | $4M | |
| Other Non-op | $123.2K | $265.0K | $-432.8K | $112.2K | $101.0K | $-312.9K | $82.6K | $-435.8K | $337.3K | $244.6K | $-25.0K | $43.4K | $-920.1K | $214.9K | $-1M | $30.9K | |
| Pretax Income | $-18M | $-17M | $-112M | $-43M | $-18M | $-15M | $-7M | $9M | $10M | $16M | $12M | $9M | $988.6K | $-6M | $-2M | $3M | |
| Income Tax | $56.1K | $19.3K | $31M | $-14M | $-5M | $-4M | $1M | $4M | $4M | $5M | $4M | $5M | $-355.1K | $-2M | $-9M | $401.9K | |
| Net Income | $-16M | $-15M | $-134M | $-28M | $-11M | $-9M | $-3M | $5M | $7M | $11M | $5M | $5M | $1M | $-4M | $6M | $2M | |
| EPS (Basic) | $-0.16 | $-0.15 | $-1.36 | $-0.28 | $-0.11 | $-0.09 | $-0.02 | $0.05 | $0.06 | $0.11 | $0.07 | $0.05 | $-0.02 | $-0.03 | $0.07 | $0.03 | |
| EPS (Diluted) | $-0.16 | $-0.15 | $-1.36 | $-0.28 | $-0.11 | $-0.09 | $-0.03 | $0.05 | $0.06 | $0.10 | $0.06 | $0.05 | $-0.02 | $-0.03 | $0.11 | $0.03 | |
| Shares (Basic) | 98,802,810 | 98,746,095 | · | 97,808,976 | 98,931,293 | 101,594,579 | · | 102,067,579 | 101,840,612 | 103,818,362 | · | 103,874,845 | 103,585,661 | 102,579,291 | · | 98,960,538 | |
| Shares (Diluted) | 98,802,810 | 98,746,095 | · | 97,808,976 | 98,931,293 | 101,594,579 | · | 106,290,929 | 106,324,345 | 108,506,435 | · | 104,993,729 | 103,585,661 | 102,579,291 | · | 107,403,135 | |
| EBITDA | · | $-16M | · | $-38M | $-13M | $-10M | · | $10M | $10M | $17M | · | $9M | · | $-7M | · | $4M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $36M | $51M | $73M | $104M | $79M | $89M | $89M | $66M | $41M | $59M | $53M | $109M | $120M | $157M | $170M | |
| Receivables | $86M | $94M | $93M | $107M | $123M | $179M | $211M | $234M | $258M | $283M | · | $207M | $118M | · | · | $80M | |
| Prepaid Expense | $4M | $5M | $5M | $5M | $10M | $5M | $4M | $5M | $5M | $11M | · | $7M | $7M | $7M | · | $2M | |
| Other Current Assets | $4M | $3M | $4M | $5M | · | · | $338.7K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $120M | $138M | $152M | $190M | $237M | $263M | $304M | $328M | $329M | $335M | · | $267M | $234M | $258M | · | $252M | |
| PP&E (Net) | $13M | $14M | $15M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | · | $22M | $22M | $22M | · | $18M | |
| PP&E (Gross) | $36M | $36M | $36M | $35M | $34M | $33M | $33M | $32M | $31M | $30M | · | $35M | $33M | $32M | · | $28M | |
| Accum. Depreciation | $24M | $23M | $22M | $21M | $19M | $18M | $18M | $17M | $15M | $14M | · | $13M | $12M | $10M | · | $11M | |
| Goodwill | $0 | $0 | $0 | $41M | $50M | $50M | $47M | $48M | $48M | $47M | $48M | $48M | $48M | $48M | $39M | $35M | |
| Intangibles | $1M | $644.1K | $0 | $18M | $27M | $27M | $26M | $35M | $36M | $37M | · | $39M | $38M | $39M | · | $21M | |
| Other Non-current Assets | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $2M | $2M | · | $3M | $4M | $3M | · | $3M | |
| Total Assets | $187M | $209M | $217M | $354M | $408M | $431M | $456M | $494M | $488M | $491M | $490M | $420M | $390M | $408M | $393M | $356M | |
| Accounts Payable | $14M | $14M | $11M | $8M | $10M | $21M | $28M | $35M | $31M | $26M | · | $9M | $7M | $19M | · | $12M | |
| Accrued Liabilities | $40M | $45M | $43M | $51M | $45M | $41M | $50M | $60M | $63M | $70M | · | $59M | $35M | $31M | · | $39M | |
| Short-term Debt | $48.0K | $49.3K | $51.7K | $54.2K | $12.6K | $12.9K | $12.5K | $26.4K | $25.5K | $26.4K | · | $13M | $18M | $649.8K | · | $680.7K | |
| Current Liabilities | $72M | $77M | $67M | $74M | $100M | $108M | $122M | $150M | $154M | $160M | · | $113M | $92M | $109M | · | $71M | |
| Capital Leases | $6M | $7M | $8M | $8M | $9M | $10M | $9M | $9M | $7M | $7M | · | $7M | $7M | $7M | · | $6M | |
| Total Liabilities | $91M | $98M | $91M | $93M | $121M | $129M | $140M | $169M | $170M | $176M | · | $128M | $106M | $124M | · | $85M | |
| Long-term Debt | $207.4K | $221.0K | $235.6K | $249.9K | $12.6K | $15.1K | · | $47.7K | $52.8K | $60.1K | · | $3M | $2M | · | · | · | |
| Total Debt | · | $270.3K | · | $304.0K | $25.2K | $28.0K | · | $74.1K | $78.3K | $86.5K | · | $16M | · | $1M | · | $1M | |
| Common Stock | $9.9K | $9.9K | $9.9K | $9.8K | $9.8K | $10.0K | $10.2K | $10.2K | $10.2K | $10.3K | · | $10.4K | $10.4K | $10.3K | · | $10.8K | |
| Paid-in Capital | $331M | $329M | $325M | $318M | $317M | $318M | $321M | $321M | $317M | $320M | · | $316M | $312M | $310M | · | $302M | |
| Retained Earnings | $-214M | $-199M | $-184M | $-50M | $-22M | $-11M | $-1M | $2M | $-4M | $-10M | · | $-29M | $-34M | $-32M | · | $-37M | |
| AOCI | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | $1M | $1M | · | $808.2K | $1M | $984.9K | · | $-276.2K | |
| Stockholders' Equity | $119M | $132M | $144M | $271M | $297M | $309M | $321M | $325M | $315M | $311M | · | $288M | $280M | $279M | · | $264M | |
| Liabilities + Equity | $187M | $209M | $217M | $354M | $408M | $431M | $456M | $494M | $488M | $491M | · | $420M | $390M | $408M | · | $356M | |
| Shares Outstanding | 98,858,369 | 98,778,413 | 98,640,059 | 97,810,755 | 97,757,075 | 100,183,888 | 101,910,883 | 101,980,995 | 101,682,770 | 102,961,495 | 104,055,168 | 103,874,539 | 103,762,092 | 102,932,174 | 102,411,162 | 102,824,878 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $12M | $2M | $2M | $1M | $8M | $1M | |
| Stock-based Comp | $3M | $3M | $3M | $5M | $5M | $5M | $4M | $3M | $3M | $4M | $6M | $3M | $3M | $8M | $3M | $1M | |
| Amort. of Intangibles | $62.0K | $21.0K | $1M | $1M | $1M | $1M | $776.5K | $2M | $2M | $2M | $953.4K | $2M | $1M | $1M | $945.4K | $990.3K | |
| Other Non-cash | · | $4M | · | · | · | $12M | · | · | · | $-27M | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-5M | $-10M | $2M | $34M | $9M | $13M | $31M | $37M | $-11M | $-6M | $-46M | $11M | $-23M | $-9M | $7M | |
| CapEx | $320.8K | $430.3K | $1M | $876.2K | $702.5K | $1M | $724.8K | $733.0K | $1M | $951.7K | $3M | $801.2K | $2M | $2M | $1M | $1M | |
| Investing Cash Flow | $-4M | $2M | $-13M | $1M | $-21M | $-5M | $-5M | $-1M | $-2M | $-2M | $-3M | $-2M | $-24M | $-2M | $-654.0K | $-36M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $727.2K | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $5M | $6M | $3M | $1M | $5M | $5M | $0 | $0 | $0 | $0 | $3M | $-140 | |
| Net Stock Activity | · | $0 | · | · | · | $-6M | · | · | · | $-5M | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-2M | $-2M | $-33M | $-7M | $-9M | $-8M | $-7M | $-8M | $-881.6K | $13M | $-9M | $9M | $-12M | $-7M | $-436.4K | |
| Net Change in Cash | $-15M | $-6M | $-25M | $-31M | $5M | $-4M | $-1M | $23M | $27M | $-13M | $5M | $-57M | $-4M | $-37M | $-15M | $-29M | |
| Taxes Paid | $154.4K | $15.8K | $-165.9K | $554.2K | $4M | $2M | $-661.9K | $5M | $813.7K | $557.6K | $6M | $0 | $4M | $40.0K | $587.8K | $155.6K | |
| Free Cash Flow | · | $-5M | · | · | · | $8M | · | · | · | $-12M | · | · | · | $-25M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -24.8% | · | -59.3% | -21.7% | -14.6% | · | 7.3% | 6.2% | 8.3% | · | 4.7% | · | -6.1% | · | 4.0% | |
| Net Margin | · | -19.5% | · | -39.2% | -13.9% | -11.5% | · | 3.3% | 3.5% | 5.5% | · | 2.5% | · | -3.1% | · | 2.4% | |
| Pretax Margin | · | -22.1% | · | -61.0% | -22.3% | -15.4% | · | 6.5% | 5.8% | 8.2% | · | 4.9% | · | -5.3% | · | 2.8% | |
| EBITDA Margin | · | -21.3% | · | -53.7% | -16.8% | -10.7% | · | 7.3% | 6.2% | 9.0% | · | 4.7% | · | -6.1% | · | 4.0% | |
| ROA | · | -4.6% | · | -6.6% | -2.5% | -2.4% | · | 1.0% | 1.3% | 2.4% | · | 1.2% | · | -0.95% | · | 1.1% | |
| ROE | · | -6.7% | · | -9.3% | -3.6% | -3.6% | · | 1.5% | 2.0% | 3.6% | · | 1.7% | · | -1.4% | · | 2.0% | |
| ROIC | · | -14.1% | · | -10.7% | -4.4% | -3.4% | · | 1.6% | 2.0% | 3.4% | · | 1.5% | · | -1.6% | · | 1.4% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.8 | · | 2.6 | 2.4 | 2.4 | · | 2.2 | 2.1 | 2.1 | · | 2.4 | · | 2.4 | · | 3.5 | |
| Quick Ratio | · | 1.7 | · | 2.5 | 2.3 | 2.4 | · | 2.2 | 2.1 | 2.0 | · | 2.3 | · | 1.1 | · | 3.5 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.5 | · | 0.3 | · | 0.4 | |
| Receivables Turnover | 0.7 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.6 | 0.9 | 1.1 | · | 1.3 | · | · | · | 2.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.20 | $1.34 | · | $2.77 | $3.04 | $3.09 | · | $3.19 | $3.10 | $3.02 | · | $2.77 | · | $2.71 | · | $2.57 | |
| Revenue / Share | $0.74 | $0.77 | · | $0.72 | $0.81 | $0.95 | · | $1.30 | $1.55 | $1.77 | · | $1.78 | · | $1.10 | · | $0.97 | |
| Cash Flow / Share | · | $-0.05 | · | · | · | $0.10 | · | · | · | $-0.10 | · | · | · | $-0.23 | · | · | |
| Cash / Share | $0.26 | $0.36 | · | $0.75 | $1.07 | $0.79 | · | $0.88 | $0.65 | $0.40 | · | $0.51 | · | $1.17 | · | $1.65 | |
| EPS (TTM) | $-1.95 | $-1.90 | · | $-0.51 | $-0.18 | $-0.01 | · | $0.27 | $0.27 | $0.19 | · | $0.11 | $0.09 | $0.22 | · | $18.66 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $295M | $302M | · | $368M | $436M | $521M | · | $695M | $743M | $703M | · | $534M | $452M | $436M | · | $453M | |
| Net Income TTM | $-192M | $-188M | · | $-52M | $-18M | $-640.6K | · | $28M | $27M | $22M | · | $8M | $12M | $16M | · | $45M | |
| Market Cap | $51M | $62M | · | $133M | $153M | $264M | · | $339M | $314M | $416M | · | $554M | · | $890M | · | $1.02B | |
| Enterprise Value | $26M | $27M | · | $60M | $49M | $186M | · | $249M | $248M | $375M | · | $516M | · | $772M | · | $852M | |
| P/E | -0.3 | -0.3 | · | -2.7 | -8.7 | -264.0 | · | 12.3 | 11.4 | 21.3 | · | 48.5 | 104.1 | 39.3 | · | 0.5 | |
| P/S | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.5 | · | 0.5 | 0.4 | 0.6 | · | 1.0 | · | 2.0 | · | 2.3 | |
| P/B | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.9 | · | 1.0 | 1.0 | 1.3 | · | 1.9 | · | 3.2 | · | 3.9 | |
| P / Tangible Book | 0.4 | 0.5 | · | 0.6 | 0.7 | 1.1 | · | 1.4 | 1.4 | 1.8 | · | 2.7 | 5.0 | 4.6 | · | 4.9 | |
| P / Cash Flow | · | -13.3 | · | · | · | 27.4 | · | · | · | -39.1 | · | · | · | -38.5 | · | · | |
| EV / Revenue | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.4 | · | 0.4 | 0.3 | 0.5 | · | 1.0 | · | 1.8 | · | 1.9 | |
| Earnings Yield | -377.9% | -302.1% | · | -37.5% | -11.5% | -0.38% | · | 8.1% | 8.7% | 4.7% | · | 2.1% | 0.96% | 2.5% | · | 188.1% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Umsatz | $322M | · | · | $617M | · |
| Betriebsgewinnmarge % | -55.3% | · | · | 4.7% | · |
| Nettoergebnis | $-182M | · | · | $20M | · |
| Verwässerte EPS | $-1.84 | · | · | $0.18 | · |
| Kennzahl | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | · | · | 0.0 | · |
| Liquiditätsgrad | 2.3 | · | · | 2.5 | · |
| Quick Ratio | 2.1 | · | · | 2.5 | · |
| Kennzahl | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Freier Cashflow | $30M | · | · | $67M | · |
Institutionelle Eigentümer (13F) 124 Einreicher · $21.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
124
Gehaltener Wert
$21.0M
Neue Positionen
27
Geschlossene Positionen
27
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 27 (-4 vs. Vorquartal) | 27 (+7 vs. Vorquartal) | 37 (+8 vs. Vorquartal) | 31 (0 vs. Vorquartal) | -4.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4.471.611 | 5.092.950 | 21,34% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.923.755 | 3.728.207 | 9,18% | Aktien |
| Knott David M Jr | $1.378.426 | 2.670.850 | 6,58% | Aktien |
| Peapod Lane Capital LLC | $1.290.311 | 2.500.118 | 6,16% | Aktien |
| CITADEL ADVISORS LLC | $1.214.699 | 2.353.610 | 5,80% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.163.480 | 2.254.370 | 5,55% | Aktien |
| S SQUARED TECHNOLOGY, LLC | $1.060.725 | 2.055.271 | 5,06% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $881.994 | 1.708.962 | 4,21% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $756.087 | 1.465.000 | 3,61% | Aktien |
| BlackRock, Inc. | $750.442 | 1.454.063 | 3,58% | Aktien |
| ISTHMUS PARTNERS, LLC | $615.179 | 1.191.977 | 2,94% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $550.313 | 1.065.850 | 2,63% | Aktien |
| FRANKLIN RESOURCES INC | $433.857 | 840.645 | 2,07% | Aktien |
| RBF Capital, LLC | $335.465 | 650.000 | 1,60% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $311.380 | 603.449 | 1,49% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $225.030 | 436.021 | 1,07% | Aktien |
| STATE STREET CORP | $217.443 | 421.319 | 1,04% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $177.389 | 343.711 | 0,85% | Aktien |
| MACKENZIE FINANCIAL CORP | $174.894 | 338.877 | 0,83% | Aktien |
| BROWN ADVISORY INC | $174.708 | 338.515 | 0,83% | Aktien |
| Marquette Asset Management, LLC | $174.620 | 338.344 | 0,83% | Aktien |
| UBS Group AG | $172.242 | 333.804 | 0,82% | Aktien |
| XTX Topco Ltd | $143.618 | 278.275 | 0,69% | Aktien |
| Summit Financial, LLC | $138.824 | 268.987 | 0,66% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $134.284 | 260.241 | 0,64% | Aktien |
| IEQ CAPITAL, LLC | $125.942 | 244.026 | 0,60% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $121.335 | 235.099 | 0,58% | Aktien |
| NORTHERN TRUST CORP | $104.293 | 202.080 | 0,50% | Aktien |
| Cresset Asset Management, LLC | $94.623 | 183.343 | 0,45% | Aktien |
| GOLDMAN SACHS GROUP INC | $90.710 | 175.760 | 0,43% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $88.850 | 172.156 | 0,42% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $84.133 | 163.017 | 0,40% | Aktien |
| Empowered Funds, LLC | $79.394 | 153.835 | 0,38% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $79.394 | 153.835 | 0,38% | Aktien |
| JPMORGAN CHASE & CO | $78.583 | 152.264 | 0,37% | Aktien |
| Invesco Ltd. | $55.455 | 107.451 | 0,26% | Aktien |
| DIVERSIFY WEALTH MANAGEMENT, LLC | $53.235 | 84.514 | 0,25% | Aktien |
| Diversify Advisory Services, LLC | $53.235 | 84.514 | 0,25% | Aktien |
| Jain Global LLC | $51.753 | 100.277 | 0,25% | Aktien |
| BBR PARTNERS, LLC | $44.283 | 85.804 | 0,21% | Aktien |
| Mariner, LLC | $43.071 | 83.454 | 0,21% | Aktien |
| MORGAN STANLEY | $39.856 | 77.227 | 0,19% | Aktien |
| PRUDENTIAL FINANCIAL INC | $39.740 | 77.000 | 0,19% | Aktien |
| Squarepoint Ops LLC | $38.078 | 73.781 | 0,18% | Aktien |
| Cerity Partners LLC | $36.247 | 70.233 | 0,17% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $32.970 | 55.226 | 0,16% | Aktien |
| TWO SIGMA ADVISERS, LP | $31.776 | 36.200 | 0,15% | Aktien |
| CWM, LLC | $28.475 | 45.263 | 0,14% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $24.248 | 46.983 | 0,12% | Aktien |
| Arax Advisory Partners | $22.181 | 42.979 | 0,11% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Vashovsky Stanley | 26. Februar 2026 | 0,20% | Änderung | · | SEC |
| Stanley Vashovsky (2) ×2 Einreichungen | 29. November 2024 | · | Erste Einreichung | Passive Anlage | SEC |
| Motion Acquisition, LLC, James Travers, Michael Burdiek, Richard Vitelle, Garo Sarkissian | 26. August 2021 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 16 Insider · 7 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lee Bienstock | Chief Executive Officer | 12. Mai 2026 F | 2.801.826 | 0 | 0 | $0 |
| Anthony Capone | Chief Executive Officer | 1. September 2023 S | 404.275 | 0 | 0 | $0 |
| Norman Rosenberg | CFO and Treasurer | 15. Dezember 2025 F | 1.223.571 | 0 | 0 | $0 |
| Stephen Sugrue | Chief Compliance Officer | 15. Dezember 2025 F | 636.602 | 0 | 0 | $0 |
| Adriaan Stephanus Oberholzer | Treasurer and Executive Vice President of Capital Markets and Strategy | 15. August 2023 S | 1.114.384 | 0 | 0 | $0 |
| Mark Do Merlin | CMO (Ambulnz Holdings, LLC) | 28. April 2022 A | · | 0 | 0 | $0 |
| Michael S. Witkowski | Chief Compliance Officer | 7. Dezember 2021 A | · | 0 | 0 | $0 |
| Ira Smedra | Direktor | 12. Dezember 2025 A | 240.999 | 0 | 0 | $0 |
| Etalvina Leite | Direktor | 12. Dezember 2025 A | 201.411 | 0 | 0 | $0 |
| Stephen K. Klasko M.D. | Direktor | 10. September 2025 A | 115.000 | 0 | 0 | $0 |
| Vashovsky Stanley | Direktor | 15. März 2024 A | 7.712.500 | 0 | 0 | $0 |
| Steven Katz | Direktor | 15. März 2024 P | 69.534 | 0 | 0 | $0 |
| Christopher Fillo | Direktor | 7. Dezember 2021 A | · | 0 | 0 | $0 |
| Ely D Tendler | · | 15. Dezember 2025 S | 258.795 | 0 | 1 | $-15.334 |
| Michael J Burdiek | · | 12. Dezember 2025 A | 791.560 | 0 | 0 | $0 |
| James M Travers | · | 12. Dezember 2025 A | 240.999 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 104.864 SH | 2. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 961.404 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.664.541 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 260.241 SH | 19. August 2026 | Täglich |
DCGO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$1.75
+373,7%
3 27,3%
Starker Kauf
4 36,4%
Kauf
4 36,4%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-09-29Mittelwert-Ziel $1.88 +407,5%
← Unter allen Zielen
Aktueller Preis $0.37
Tief$1.00
Mittelwert$1.88
Hoch$3.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 17, 2026